000403 派林生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产269-2.54%276305333362
固定资产1,800,352-1.67%1,830,9021,462,343942,994873,673
在建工程231,9462.64%225,989513,359582,700385,735
无形资产187,163-1.61%190,220200,333212,593192,516
商誉2,536,0100.00%2,536,0102,614,6122,614,6122,614,612
其他非流动资产1,076,75811.94%961,944876,369851,167868,452
5,832,4981.52%5,745,3415,667,3215,204,3994,935,349

流动资产
货币资金435,529-43.45%770,1581,321,1241,429,3501,000,797
应收账款842,871-9.33%929,584631,222583,579835,877
存货1,791,79214.60%1,563,4741,233,249909,375623,689
其他流动资产480,0274.86%457,793393,354503,771586,612
3,550,220-4.59%3,721,0083,578,9493,426,0753,046,976

流动负债
短期借款536,3100.11%535,704310,489250,571275,102
应付票据0-100.00%3,9853,93200
应付帐款133,711-11.61%151,275220,324154,347158,370
其他流动负债382,626-12.55%437,520422,226517,276525,837
1,052,647-6.72%1,128,483956,972922,195959,309
流动资产净值2,497,573-3.66%2,592,5252,621,9772,503,8802,087,667
资产总额减流动负债8,330,070-0.09%8,337,8668,289,2987,708,2807,023,016

非流动负债
长期借款161,849-16.50%193,828303,221196,07952,886
应付债券0--0000
其他非流动负债64,2512.33%62,78868,57390,337109,002
226,100-11.89%256,617371,795286,416161,888

总权益
    实收股本950,3970.00%950,397731,075733,001732,387
    储备项目7,160,5890.32%7,137,6307,193,5766,695,6496,135,137
股东权益8,110,9860.28%8,088,0277,924,6517,428,6496,867,524
非控股权益(7,016)3.50%(6,779)(7,148)(6,785)(6,397)